Connection

Alexandre Mebazaa to Angiotensin Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Alexandre Mebazaa has written about Angiotensin Receptor Antagonists.
Alexandre Mebazaa
Connection Strength
0.183
Angiotensin Receptor Antagonists
  1. Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial). Trials. 2019 Mar 05; 20(1):160.
    View in: PubMed
    Score: 0.060
  2. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. 2018 May; 44(5):598-605.
    View in: PubMed
    Score: 0.056
  3. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 02; 20(2):345-354.
    View in: PubMed
    Score: 0.054
  4. Effectiveness of guideline-consistent heart failure drug prescriptions at hospital discharge on 1-year mortality: Results from the EPICAL2 cohort study. Eur J Intern Med. 2018 05; 51:53-60.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.